Table 4.
Correlation between disease severity and quality of life measures.
| Skindex-29 | |||||
|---|---|---|---|---|---|
| Pearson's r (95% CI) | Emotions | Symptoms | Functioning | DLQIa | SHQ Total Score |
| CSAMI Activity | 0.74 (0.26 – 0.93) | 0.29 (−0.38 – 0.76) | 0.59 (−0.02 – 0.88) | 0.35 (−0.31 – 0.79) | −0.39 (−0.80 – 0.28) |
| CSAMI Damage | 0.54 (−0.09 – 0.86) | 0.51 (−0.13 – 0.85) | 0.68 (0.13 – 0.91) | 0.29 (−0.38 – 0.76) | −0.16 (−0.69 – 0.49) |
| Modified Facial SASI | 0.15 (−0.53 – 0.71) | 0.22 (−0.47 – 0.75) | 0.24 (−0.46 – 0.76) | 0.20 (−0.50 – 0.74) | 0.13 (−0.54 – 0.70) |
| PGA | 0.47 (−0.18 – 0.84) | 0.41 (−0.25 – 0.81) | 0.38 (−0.28 – 0.80) | 0.24 (−0.42 – 0.73) | −0.18 (−0.70 – 0.47) |
Abbreviations: CI, confidence interval; CSAMI, Cutaneous Sarcoidosis Activity and Morphology Instrument; SASI, Sarcoidosis Activity and Severity Index; PGA, Physician's Global Assessment; DLQI, Dermatology Life Quality Index; SHQ, Sarcoidosis Health Questionnaire.
a
Spearman's ρ was used since DLQI scores were not normally distributed.